Exane Derivatives’s LinkedIn Corporation LNKD Stock Holding History

Exane Derivatives’s Portfolio LNKD Stock Details LNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,052	Closed	-$578K	–	668
2016 Q2	$578K	Sell	3,052 -5,883	-66%	-$815K	0.1%	123
2016 Q1	$1.02M	Buy	8,935 +6,804	+319%	+$999K	0.14%	89
2015 Q4	$480K	Sell	2,131 -1,662	-44%	-$377K	0.07%	119
2015 Q3	$721K	Sell	3,793 -597	-14%	-$119K	0.09%	104
2015 Q2	$907K	Buy	4,390 +2,830	+181%	+$631K	0.1%	96
2015 Q1	$390K	Buy	1,560 +140	+10%	+$34.8K	0.04%	162
2014 Q4	$326K	Buy	+1,420	New	+$308K	0.05%	176

Other funds holding LNKD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SIM

SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Exane Derivatives's LNKD Position: Q3 2016 in Review

Exane Derivatives sold out of LinkedIn Corporation (LNKD) in Q3 2016, closing a stake of 3,052 shares — an estimated $578K sold.

Exane Derivatives first reported a position in LNKD in Q4 2014 and held it in 7 quarters. The position peaked at $1.02M in Q1 2016. 454 funds tracked by Wall St. Rank hold LNKD as of Q3 2016.

Exane Derivatives reported no remaining LinkedIn Corporation position as of Q3 2016 after selling out during the quarter.
Exane Derivatives sold 3,052 LinkedIn Corporation shares in Q3 2016, an estimated $578K.
Exane Derivatives first reported a position in LinkedIn Corporation in Q4 2014 and held it in 7 quarters.
Exane Derivatives's LinkedIn Corporation position peaked at $1.02M in Q1 2016.
454 funds tracked by Wall St. Rank held LinkedIn Corporation as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.